Dr. Reddy’s Laboratories
Signals mentioning Dr. Reddy’s Laboratories
- Dr. Reddy’s to bring Takeda’s QDENGA dengue vaccine to India’s private market in H1 2027
- Dr Reddy’s to distribute Takeda’s QDENGA dengue vaccine in India from H1 2027
- Dr Reddy’s partners with Takeda to distribute Qdenga dengue vaccine in India
- Dr Reddy’s wins exclusive private-market distribution rights for Takeda’s QDENGA in India
- Dr Reddy’s to exclusively distribute Takeda’s Qdenga dengue vaccine in India from H1 2027
- Dr Reddy’s to distribute Takeda’s Qdenga dengue vaccine in India
- Dr Reddy’s to exclusively distribute Takeda’s Qdenga dengue vaccine in India’s private market
- Dr Reddy’s to distribute Takeda’s QDENGA dengue vaccine in India’s private market
- India pharma market grows 13% in August as GLP-1 therapies accelerate
- IPC to set uniform semaglutide quality standards as Indian generic market expands
- Asian Paints names Leo Puri as chairman-designate for January 2027
- Nestlé India, Tata Consumer and beauty brands target India’s emerging GLP-1 consumer market
- Indian consumer brands target GLP-1 users with collagen, protein and beauty products
- JPMorgan sees volume-led consumer staples recovery as ITC weighs on Nifty
- Dixon backs Padget with $220m guarantee for Lenovo component purchases
- Dr Reddy’s ends Novartis India distribution pact after ownership change
- India opens DCGI chief search as expanded eligibility draws regulator backlash
- India pharma market grows 16% as drugmakers enter US tariff-free transition
- Dr Reddy’s Q1FY27 profit falls 69% as US sales and semaglutide supply weaken
- GTRI flags proposed US generic-drug tariffs as major risk for Indian pharma exporters